pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
MTI-201
Metastatic Uveal Melanoma
Modulation Therapeutics Inc
0
catalysts
Phase 1
MuSK-CAART
Myasthenia Gravis
$CABA
Cabaletta Bio, Inc.
0
catalysts
Phase 1
MyoPAXon
Duchenne Muscular Dystrophy
Myogenica Inc
0
catalysts
Phase 1
← prev
page 15 of 26
next →
131
Pain
89
Neurology
1
NA-731
Traumatic Brain Injury
Biomed Industries Inc
0
catalysts
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
New Amsterdam Sciences Inc
0
catalysts
Phase 1
NC-2400
Dyslipidemia
ABIONYX Pharma SA
0
catalysts
Phase 1
NIM-1324
Rheumatoid Arthritis
NImmune Biopharma Inc
0
catalysts
Phase 1
NKT-3964
Adenocarcinoma Of The Gastroesophageal Junction
NiKang Therapeutics Inc
0
catalysts
Phase 1
NLX-101
Fragile X Syndrome
Neurolixis Inc
0
catalysts
Phase 1
NM-5072
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
0
catalysts
Phase 1
NM-6603
Colorectal Cancer
Nucmito
0
catalysts
Phase 1
NMS-812
Refractory Acute Myeloid Leukemia
Nerviano Medical Sciences SRL
0
catalysts
Phase 1
NN-3201
Adenoid Cystic Carcinoma (ACC)
Novelty Nobility Inc
0
catalysts
Phase 1
NNI-362
Alzheimer's Disease
NeuroNascent Inc
0
catalysts
Phase 1
NO-13065
Obesity
Otsuka Pharmaceutical Co Ltd
0
catalysts
Phase 1
NOVA-1010
Schizophrenia
Novastage Pharmaceuticals (Shenzhen) Ltd
0
catalysts
Phase 1
NP-10679
Subarachnoid Hemorrhage
NeurOp Inc
0
catalysts
Phase 1
NP-3
Nephropathic Cystinosis
Nacuity Pharmaceuticals Inc
0
catalysts
Phase 1
NPX-887
Adenocarcinoma Of The Gastroesophageal Junction
NextPoint Therapeutics Inc
0
catalysts
Phase 1
NRL-1049
Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hema…
Neurelis Inc
0
catalysts
Phase 1
NRS-033
Opium (Opioid) Addiction
Nirsum Laboratories Inc
0
catalysts
Phase 1
NTP-42
Pulmonary Arterial Hypertension
ATXA Therapeutics Ltd
0
catalysts
Phase 1
NTS-1104
Acute Ischemic Stroke
NeuroTrauma Sciences LLC
0
catalysts
Phase 1
NVK-029
Presbyopia
Vyluma Inc
0
catalysts
Phase 1
NVK-031
Unspecified Ophthalmological Disorders
Vyluma Inc
0
catalysts
Phase 1
NX-1607
Adenocarcinoma Of The Gastroesophageal Junction
$NRIX
Nurix Therapeutics, Inc.
0
catalysts
Phase 1
NXP-900
Cervical Cancer
$NVCT
Nuvectis Pharma, Inc.
0
catalysts
Phase 1
Nezavist
Alcohol Use Disorder (AUD)
Lohocla Research Corp
0
catalysts
Phase 1
OCF-001
Vulvovaginal Candidiasis
Sano Chemicals Inc
0
catalysts
Phase 1
OCU-200
Diabetic Macular Edema
$OCGN
Ocugen, Inc.
0
catalysts
